Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and colleagues at University of California. The company has partnerships with Novartis and Regeneron.
Basel, BS, Switzerland.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely CRISPR Therapeutics is implementing good security practices.
Read more about the latest issues in cybersecurity
The Vendor Security Alliance (VSA) questionnaire was created by a coalition of companies committed ...
Cyber security is the state or process of protecting and recovery computer systems, networks, ...
Compare CRISPR Therapeutics's security performance with other companies